Thanks to a recent study by researchers at IOCB Prague, it is now possible to monitor processes in living cells more effectively than before, including responses to drugs and changes in cellular ...
(About 43% of tumor cells were both EGFR- and antibody-negative, and about 5% of tumor cells were EGFR-negative and antibody-positive.) Further investigation identified specific stromal and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results